• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑瘤素M对于中性粒细胞调节造血干细胞/祖细胞的迁移并非必需。

Oncostatin M is dispensable for the regulation of hematopoietic stem/progenitor cell traffic by neutrophils.

作者信息

Rodella Anna, Boscaro Carlotta, Amendolagine Francesco Ivan, Migliozzi Ludovica, Molon Barbara, Viola Antonella, Albiero Mattia, Fadini Gian Paolo

机构信息

Veneto Institute of Molecular Medicine, 35100 Padova, Padua, Italy.

Department of Medicine, University of Padova, 35100 Padova, Padua, Italy.

出版信息

iScience. 2025 May 12;28(6):112646. doi: 10.1016/j.isci.2025.112646. eCollection 2025 Jun 20.

DOI:10.1016/j.isci.2025.112646
PMID:40502695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12158506/
Abstract

Hematopoietic stem/progenitor cell (HSPC) trafficking in and out of the bone marrow (BM) is essential for immune surveillance and hematopoietic balance. We previously identified Oncostatin M (OSM), primarily from myeloid cells, as a key regulator of HSPC traffic. Here, we show that neutrophils highly express and secrete OSM, especially when senesced. However, OSM is not required for neutrophil-mediated modulation of steady-state or circadian HSPC levels. Aged neutrophils returning to the BM reduce HSPC levels in peripheral blood (PB) independently of OSM, suggesting additional mechanisms beyond CXCL12/CXCR4 axis. While neutrophil transfer modulated HSPC kinetics in wild-type mice, OSM-secreting neutrophils failed to normalize elevated PB-HSPC levels in mice, though recombinant OSM successfully did. Macrophage depletion-induced HSPC egress was OSM-dependent, but neutrophil depletion elevated PB-HSPCs regardless of OSM. These findings reveal that neutrophils regulate HSPC migration via largely OSM-independent pathways, emphasizing the importance of cell-specific and context-dependent cues within the BM niche.

摘要

造血干/祖细胞(HSPC)进出骨髓(BM)对于免疫监视和造血平衡至关重要。我们之前鉴定出主要来自髓系细胞的抑瘤素M(OSM)是HSPC转运的关键调节因子。在此,我们表明中性粒细胞高度表达并分泌OSM,尤其是在衰老时。然而,中性粒细胞介导的稳态或昼夜HSPC水平调节并不需要OSM。返回骨髓的衰老中性粒细胞独立于OSM降低外周血(PB)中的HSPC水平,提示除CXCL12/CXCR4轴之外的其他机制。虽然中性粒细胞转移调节野生型小鼠中的HSPC动力学,但分泌OSM的中性粒细胞未能使小鼠中升高的PB-HSPC水平恢复正常,尽管重组OSM成功做到了这一点。巨噬细胞耗竭诱导的HSPC流出是OSM依赖性的,但中性粒细胞耗竭无论OSM如何都会升高PB-HSPCs。这些发现揭示中性粒细胞通过很大程度上不依赖OSM的途径调节HSPC迁移,强调了骨髓微环境中细胞特异性和背景依赖性线索的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/32e34c7aa2f7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/98991b44299c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/a6bb5370aa68/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/6cda0b32f128/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/81673b4492c8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/8695067cec4b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/32e34c7aa2f7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/98991b44299c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/a6bb5370aa68/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/6cda0b32f128/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/81673b4492c8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/8695067cec4b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7468/12158506/32e34c7aa2f7/gr5.jpg

相似文献

1
Oncostatin M is dispensable for the regulation of hematopoietic stem/progenitor cell traffic by neutrophils.抑瘤素M对于中性粒细胞调节造血干细胞/祖细胞的迁移并非必需。
iScience. 2025 May 12;28(6):112646. doi: 10.1016/j.isci.2025.112646. eCollection 2025 Jun 20.
2
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes.药物激活过氧化物酶体增殖物激活受体-γ可重塑骨髓巨噬细胞,并部分挽救人类和小鼠糖尿病中的 HSPC 动员。
Diabetes. 2020 Jul;69(7):1562-1572. doi: 10.2337/db19-0640. Epub 2020 Apr 28.
3
Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway.糖尿病相关的骨髓造血作用通过 OSM-p66Shc 信号通路驱动干细胞动员异常。
Diabetes. 2019 Jun;68(6):1303-1314. doi: 10.2337/db19-0080. Epub 2019 Apr 1.
4
Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.骨基质细胞衍生的 Oncostatin M 通过调节骨髓造血干细胞龛限制其动员
Leukemia. 2022 Feb;36(2):333-347. doi: 10.1038/s41375-021-01413-z. Epub 2021 Sep 13.
5
CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation.CXCR4 在骨髓微环境中的表达对于造血干细胞和祖细胞的维持以及骨髓清除后早期造血的恢复是必需的。
Stem Cells. 2020 Jul;38(7):849-859. doi: 10.1002/stem.3174. Epub 2020 Mar 19.
6
Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis.抑瘤素M通过调节脂肪生成和成骨作用维持骨髓中的造血微环境。
PLoS One. 2014 Dec 31;9(12):e116209. doi: 10.1371/journal.pone.0116209. eCollection 2014.
7
GSK3β regulates physiological migration of stem/progenitor cells via cytoskeletal rearrangement.GSK3β 通过细胞骨架重排调节干细胞/祖细胞的生理迁移。
J Clin Invest. 2013 Apr;123(4):1705-17. doi: 10.1172/JCI64149. Epub 2013 Mar 8.
8
Egress and Mobilization of Hematopoietic Stem and Progenitor Cells: A Dynamic Multi-facet Process造血干细胞和祖细胞的迁出与动员:一个动态的多方面过程
9
Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems.抑瘤素M:骨骼和造血系统的双重调节因子
Curr Osteoporos Rep. 2024 Feb;22(1):80-95. doi: 10.1007/s11914-023-00837-z. Epub 2024 Jan 10.
10
Expansion of bone marrow neutrophils following G-CSF administration in mice results in osteolineage cell apoptosis and mobilization of hematopoietic stem and progenitor cells.G-CSF 给药后小鼠骨髓中性粒细胞的扩增导致成骨细胞凋亡和造血干细胞和祖细胞的动员。
Leukemia. 2012 Nov;26(11):2375-83. doi: 10.1038/leu.2012.117. Epub 2012 Apr 30.

本文引用的文献

1
Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis.循环造血干/祖细胞亚群有助于维持人体造血稳态。
Blood. 2024 May 9;143(19):1937-1952. doi: 10.1182/blood.2023022666.
2
Circulating haematopoietic stem cells and long-term outcomes of COVID-19.循环造血干细胞与 COVID-19 的长期结局。
Eur J Clin Invest. 2024 Apr;54(4):e14150. doi: 10.1111/eci.14150. Epub 2023 Dec 13.
3
Macrophage heterogeneity in the single-cell era: facts and artifacts.单细胞时代的巨噬细胞异质性:事实与假象。
Blood. 2023 Oct 19;142(16):1339-1347. doi: 10.1182/blood.2023020597.
4
Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes.氯膦酸脂质体的抗炎作用是通过中性粒细胞耗竭来实现的。
J Exp Med. 2023 Jun 5;220(6). doi: 10.1084/jem.20220525. Epub 2023 Mar 28.
5
Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice.造血细胞源性制瘤素M的缺失会加重小鼠饮食诱导的代谢紊乱。
Diabetes. 2023 Apr 1;72(4):483-495. doi: 10.2337/db22-0054.
6
Impaired Hematopoietic Stem/Progenitor Cell Traffic and Multi-organ Damage in Diabetes.糖尿病导致造血干/祖细胞运输受损和多器官损伤。
Stem Cells. 2022 Aug 25;40(8):716-723. doi: 10.1093/stmcls/sxac035.
7
The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans.智慧人图谱:人类多器官单细胞转录组图谱。
Science. 2022 May 13;376(6594):eabl4896. doi: 10.1126/science.abl4896.
8
Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.致命性新冠肺炎中的肺部炎症反应揭示了III/IV期临床试验中的潜在治疗靶点和药物。
Front Pharmacol. 2022 Mar 29;13:833174. doi: 10.3389/fphar.2022.833174. eCollection 2022.
9
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19.高血糖、造血干细胞减少与 COVID-19 结局的关系。
Diabetes. 2022 Apr 1;71(4):788-794. doi: 10.2337/db21-0965.
10
Fragmentation of tissue-resident macrophages during isolation confounds analysis of single-cell preparations from mouse hematopoietic tissues.组织驻留巨噬细胞在分离过程中的碎片化会混淆从小鼠造血组织中单细胞制剂的分析。
Cell Rep. 2021 Nov 23;37(8):110058. doi: 10.1016/j.celrep.2021.110058.